SANUWAVE Health, Inc.
SNWV
$29.89
-$1.06-3.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -9.53% | 10.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.53% | 10.32% | |||
| Cost of Revenue | -14.31% | -0.35% | |||
| Gross Profit | -8.17% | 13.78% | |||
| SG&A Expenses | 16.60% | 8.36% | |||
| Depreciation & Amortization | -13.12% | 7.28% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.07% | 5.36% | |||
| Operating Income | -60.90% | 29.13% | |||
| Income Before Tax | 55.38% | 38.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 55.48% | 38.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 55.48% | 38.29% | |||
| EBIT | -60.90% | 29.13% | |||
| EBITDA | -59.23% | 32.68% | |||
| EPS Basic | 56.18% | 76.64% | |||
| Normalized Basic EPS | 59.64% | 74.63% | |||
| EPS Diluted | 56.18% | 76.64% | |||
| Normalized Diluted EPS | 59.64% | 74.63% | |||
| Average Basic Shares Outstanding | 1.60% | 164.16% | |||
| Average Diluted Shares Outstanding | 1.60% | 164.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||